---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-22-171921"
form_type: "8-K"
ticker: "CUE"
cik: "0001645460"
company_name: "Cue Biopharma, Inc."
filed_at: "2022-06-10T23:59:59+00:00"
generated_at: "2026-06-25T02:47:01.235610+00:00"
event_type: "other"
sentiment: "neutral"
materiality_score: 0.25
calibrated_materiality_score: 0.15
confidence: "high"
source: SEC EDGAR
---

# Cue Biopharma reports 2022 annual meeting voting results

## Summary
- All seven director nominees elected (Driscoll, Fletcher, Gray, Howson, Kiener, Morich, Passeri).
- Ratification of RSM US LLP as independent auditor for FY 2022 approved with 26,125,468 votes for.
- Broker non-votes of 14,293,960 on director elections; no other proposals were voted on.
- Meeting held June 9, 2022; results filed on June 10, 2022.

## SEC filing metadata
- accession: 0001193125-22-171921
- form_type: 8-K
- ticker: CUE
- cik: 0001645460
- company_name: Cue Biopharma, Inc.
- filed_at: 2022-06-10T23:59:59+00:00
- event_type: other
- sentiment: neutral
- materiality_score: 0.25
- calibrated_materiality_score: 0.15
- confidence: high
- sec_items: 5.07
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1645460/000119312522171921/0001193125-22-171921-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1645460/000119312522171921/d370247d8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-22-171921
- JSON: https://secwatch.observer/filing/0001193125-22-171921.json
- Plain text: https://secwatch.observer/filing/0001193125-22-171921.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.